| Name | ADPGK antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ADPGK‐AS1 is emerging as an oncogenic long non‐coding RNA that is up‐regulated in multiple cancer types and contributes to tumor progression by functioning as a competing endogenous RNA. In pancreatic cancer, ADPGK‐AS1 promotes tumorigenesis and the epithelial–mesenchymal transition (EMT) by sponging miR‑205‑5p, thereby up‐regulating ZEB1 and enhancing proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In colorectal cancer, elevated ADPGK‐AS1 levels contribute to malignant behavior through a regulatory loop in which it binds miR‑525, leading to increased expression of FUT1, thus promoting cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In gastric cancer, ADPGK‐AS1 acts as a sponge for miR‑3196 to relieve the inhibition of KDM1B, facilitating cancer progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Similarly, in osteosarcoma, ADPGK‐AS1 is up‐regulated and contributes to enhanced proliferation, migration, and invasion while inhibiting apoptosis by targeting miR‑542‑3p."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond these direct mechanistic studies, a high‐throughput RNA interference screen in Drosophila has implicated ADPGK‐AS1—as part of a genomic region linked to adiposity-related SNPs—as a potential functional gene in metabolic regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, integrative bioinformatic analyses have identified ADPGK‐AS1 as a co-expressed long non-coding RNA associated with druggable pathways in prostate cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "and as a component of an eight-lncRNA prognostic signature linked to poor outcomes in cervical cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In breast cancer, particularly in triple-negative subtypes, high ADPGK‐AS1 expression is associated with distant metastasis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", and in a separate study it was demonstrated that ADPGK‐AS1 promotes cell proliferation, migration, EMT, and survival by sponging miR‑3196 to consequently up-regulate OTX1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies underscore the role of ADPGK‐AS1 as an oncogenic factor that modulates key microRNAs and their downstream effectors in a cancer-type–dependent manner, highlighting its potential value as both a prognostic biomarker and a therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Suzhen Song, Weihua Yu, Sen Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2018.1423912"}], "href": "https://doi.org/10.1080/15384047.2018.1423912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29667486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29667486"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H-Y Jiang, Z-J Wang "}, {"type": "b", "children": [{"type": "t", "text": "ADPGK-AS1 promotes the progression of colorectal cancer via sponging miR-525 to upregulate FUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202003_20505"}], "href": "https://doi.org/10.26355/eurrev_202003_20505"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32196589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32196589"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhen Huang, Hua Yang "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of the long noncoding RNA ADPGK-AS1 promotes carcinogenesis and predicts poor prognosis in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.03.140"}], "href": "https://doi.org/10.1016/j.bbrc.2019.03.140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30944080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30944080"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "X-F Luo, X-J Wu, X Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201910_19269"}], "href": "https://doi.org/10.26355/eurrev_201910_19269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31696461"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31696461"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Thomas J Baranski, Aldi T Kraja, Jill L Fink, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1007222"}], "href": "https://doi.org/10.1371/journal.pgen.1007222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29608557"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29608557"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Simona De Summa, Antonio Palazzo, Mariapia Caputo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22042227"}], "href": "https://doi.org/10.3390/ijms22042227"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33672425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33672425"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Qihang Zhong, Minzhen Lu, Wanqiong Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-021-02705-9"}], "href": "https://doi.org/10.1186/s12967-021-02705-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33557879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33557879"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shuo Zhang, Feixia Ma, Xiaohong Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000021861"}], "href": "https://doi.org/10.1097/MD.0000000000021861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32925722"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32925722"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jiahui Yang, Weizhu Wu, Minhua Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vitro Cell Dev Biol Anim (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11626-019-00372-1"}], "href": "https://doi.org/10.1007/s11626-019-00372-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31264061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31264061"}]}]}]}
|
| NCBI Gene ID | 100287559 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ADPGK-AS1 has 765 functional associations with biological entities spanning 4 categories (molecular profile, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 10 datasets.
Click the + buttons to view associations for ADPGK-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADPGK-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ADPGK-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ADPGK-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADPGK-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ADPGK-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ADPGK-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with ADPGK-AS1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ADPGK-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of ADPGK-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of ADPGK-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |